tiprankstipranks
Cara Therapeutics (CARA)
NASDAQ:CARA

Cara Therapeutics (CARA) Stock Investors

2,186 Followers
Based on 730,653 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CARA
On average, investors allocate 2.72% of their portfolios to CARA
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CARA

3.2%
Last 7
Days
8.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CARA, out of 730,653 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CARA Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
3.76%
$0.57
Opened
4.35%
$0.77
Increased
<0.01%
$0.89
Increased
<0.01%
$0.89
Reduced
0.05%
$0.62
Based on the activity of 13,728 investors who made their portfolios public
The table shows changes in CARA in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CARA Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Merck & Company
4.15%
<+0.01%
+1.85%
332.28B
Healthcare
GE Aerospace
5.52%
+0.81%
+12.29%
177.71B
Industrials
Micron
5.71%
+0.99%
+10.35%
127.17B
Technology
Block
4.45%
-0.40%
-3.75%
45.86B
Technology
Cisco Systems
4.52%
-0.44%
-0.39%
193.79B
Technology
Delta Air Lines
5.60%
-0.56%
+1.35%
32.21B
Industrials
Salesforce
4.91%
+0.32%
+4.88%
266.06B
Technology
Citigroup
5.14%
-0.22%
+0.49%
120.01B
Financial
ChargePoint Holdings
3.87%
-0.93%
-3.17%
537.67M
Consumer Cyclical
Trade Desk
4.66%
-0.32%
-1.27%
41.43B
Technology
Based on the activity of 730,653 active portfolios
Open your Smart Portfolio

CARA Investor Analysis

CARA investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
8.6%
of CARA holders
are under 35
Average Segment Performance
Average P/E Ratio56.32
Beta6.59
Dividend Yield6.13%
CARA investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
40.5%
of CARA holders
are between 35–55
Average Segment Performance
Average P/E Ratio61.35
Beta11.34
Dividend Yield17.67%
CARA investors over 55

Over 55

10.4%
Last 30 days
Holdings Change
51.0%
of CARA holders
are over 55
Average Segment Performance
Average P/E Ratio52.26
Beta4.21
Dividend Yield22.32%
Overview of age group and performance of CARA stock investors
See who invests in CARA according to age group and performance.

FAQ

How many retail Investors hold CARA?
<0.1% of TipRanks' retail investors hold CARA in their portfolios.
    What is CARA Investor Sentiment?
    CARA’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of CARA in the last 7 days?
      ▼ 3.2% of TipRanks' retail investors changed their holding of CARA in the last 7 days.
        What percentage of retail investors changed their holding of CARA in the last 30 days?
        ▼ 8.2% of TipRanks' retail investors changed their holding of CARA in the last 30 days.
          What is the average age of retail investors who hold CARA?
          The average age of CARA Holders is over 55.
            What other stocks have CARA investors also bought?
            CARA Investors also bought MRK, GE, MU, SQ, CSCO, DAL, CRM, C, CHPT, TTD.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              CORTCorcept Therapeutics
              GILDGilead Sciences
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis